Teligent Has No Explanation For Sudden Share-Price Slide

US niche generics specialist Teligent is at a loss to explain why its share price has tumbled in recent times as it ramps up production at an expanded injectables facility.

Man_Computer
Teligent is bemused by a sudden drop in its share price • Source: Shutterstock

More from Archive

More from Generics Bulletin